Concise review: Macrophages: Versatile gatekeepers during pancreatic β-cell development, injury, and regeneration

Stem Cells Translational Medicine

Volumn 4, Issue 6, 2015, Pages 555-563

  Gassen, Naomi Van ^a   Staels, Willem ^a,b,c   Overmeire, Eva Van ^d,e   De Groef, Sofie ^a   Sojoodi, Mozhdeh ^a   Heremans, Yves ^a   Leuckx, Gunter ^a   De Casteele, Mark Van ^a   Ginderachter, Jo A Van ^e   Heimberg, Harry ^a   De Leu, Nico ^a,f  

^a Diabetes Research Center   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^f UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

B Cell; Development; Injury; Macrophage; Pancreas; Regeneration

Indexed keywords

ARGINASE 1; CASPASE 9; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; IMMUNOGLOBULIN G; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN; SCATTER FACTOR; SCAVENGER RECEPTOR; SOMATOMEDIN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN;

ARTICLE; CELL ACTIVATION; CELL DAMAGE; CELL HETEROGENEITY; CELL PROLIFERATION; CELL REGENERATION; GENE EXPRESSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORGANOGENESIS; PANCREAS ISLET BETA CELL; TISSUE REPAIR; ANIMAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; METABOLISM; PANCREATITIS; PATHOLOGY; REGENERATION;

MURINAE;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN-SECRETING CELLS; MACROPHAGES; PANCREATITIS; REGENERATION;

EID: 84930535916     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0272     Document Type: Article

References (82)

1. Geissmann F, Manz MG, Jung S et al. Development of monocytes, macrophages, and dendritic cells. Science 2010;327:656–661.
2. Wynn TA, Chawla A, Pollard JW. Macro-phage biology in development, homeostasis and disease. Nature 2013;496:445–455.
3. Schulz C, Gomez Perdiguero E, Chorro L et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012;336:86–90.
4. Ginhoux F, Jung S. Monocytes and macro-phages: Developmental pathways and tissue homeostasis. Nat Rev Immunol 2014;14:392–404.
5. Hashimoto D, Chow A, Noizat C et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013;38:792–804.
6. Galli SJ, Borregaard N, Wynn TA. Pheno-typic and functional plasticity of cells of innate immunity: Macrophages, mast cells and neutrophils. Nat Immunol 2011;12: 1035–1044.
7. Mantovani A, Sica A, Sozzani S et al. The chemokine system in diverse forms of macro-phage activation and polarization. Trends Immunol 2004;25:677–686.
8. Murray PJ, Allen JE, Biswas SK et al. Mac-rophage activation and polarization:Nomencla-ture and experimental guidelines. Immunity 2014;41:14–20.
9. Xue J, Schmidt SV, Sander J et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014;40:274–288.
10. 10 Mantovani A, Biswas SK, Galdiero MR et al. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013;229:176–185.
11. Movahedi K, Laoui D, Gysemans C et al. Different tumor microenviron-ments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 2010;70:5728–5739.
12. Ghassabeh GH, De Baetselier P, Brys L et al. Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 2006;108: 575–583.
13. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol 2009;9:259–270.
14. Cecchini MG, Dominguez MG, Mocci S et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 1994;120:1357–1372.
15. Jones CV, Ricardo SD. Macrophages and CSF-1: Implications for development and beyond. Organogenesis 2013;9:249–260.
16. Geutskens SB, Otonkoski T, Pulkkinen MA et al.Macrophagesin the murinepancreas and their involvement in fetal endocrine development in vitro. J Leukoc Biol 2005;78: 845–852.
17. Banaei-Bouchareb L, Gouon-Evans V, Sa-mara-Boustani D et al. Insulin cell mass is altered in Csf1op/Csf1op macrophage-deficient mice. J Leukoc Biol 2004;76:359–367.
18. Lammert E, Cleaver O, Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science 2001;294:564–567.
19. Magenheim J, Ilovich O, Lazarus A et al. Blood vessels restrain pancreas branching, differentiation and growth. Development 2011; 138:4743–4752.
20. Johansson M, Mattsson G, Andersson A et al. Islet endothelial cells and pancreatic beta-cell proliferation: Studies in vitro and dur-ingpregnancyinadult rats.Endocrinology2006; 147:2315–2324.
21. Nucera S, Biziato D, De Palma M. The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. Int J Dev Biol 2011;55:495–503.
22. O’Reilly LA, Hutchings PR, Crocker PR et al. Characterization of pancreatic islet cell infiltrates in NOD mice: Effect of cell transfer and transgene expression. Eur J Immunol 1991; 21:1171–1180.
23. Herold KC, Vignali DA, Cooke A et al. Type 1 diabetes: Translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol 2013;13:243–256.
24. Calderon B, Suri A, Unanue ER.InCD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: Studies from an acute model. Am J Pathol 2006;169:2137–2147.
25. Jun HS, Yoon CS, Zbytnui kL et al. The role ofmacrophagesinTcell-mediatedautoimmune diabetes in nonobese diabetic mice. J Exp Med 1999;189:347–358.
26. Willcox A, Richardson SJ, Bone AJ et al. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009;155:173–181.
27. Cnop M, Welsh N, Jonas JC et al. Mecha-nismsofpancreaticbeta-celldeathintype1and type 2 diabetes: Many differences, few similarities. Diabetes 2005;54(suppl 2):S97–S107.
28. Shao S, He F, Yang Y et al. Th17 cells in type 1 diabetes. Cell Immunol 2012;280:16–21.
29. Emamaullee JA, Davis J, Merani S et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009;58:1302–1311.
30. Honkanen J, Nieminen JK, Gao R et al. IL-17 immunityin human type 1 diabetes. J Immunol 2010;185:1959–1967.
31. Ehses JA, Perren A, Eppler E et al. Increased number of islet-associated macro-phages in type 2 diabetes. Diabetes 2007;56: 2356–2370.
32. Eguchi K, Manabe I, Oishi-Tanaka Y et al. Saturated fatty acid and TLR signaling link b cell dysfunction and islet inflammation. Cell Metab 2012;15:518–533.
33. Jourdan T, Godlewski G, Cinar R et al. Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids medi- ates beta cell loss in type 2 diabetes. Nat Med 2013;19:1132–1140.
34. Nackiewicz D, Dan M, He W et al. TLR2/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6. Diabetologia 2014;57:1645–1654.
35. Martin AP, Rankin S, Pitchford S et al. Increased expressionofCCL2ininsulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow, marked insulitis, and diabetes. Diabetes 2008;57:3025–3033.
36. Weisberg SP, McCann D, Desai M et al. Obesityisassociatedwith macrophageaccumu-lation in adipose tissue. J Clin Invest 2003;112: 1796–1808.
37. Nguyen KD, Qiu Y, Cui X et al. Alternatively activated macrophages producecatecholamines tosustainadaptive thermogenesis. Nature 2011; 480:104–108.
38. Chondronikola M, Volpi E, Børsheim E et al. Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes 2014;63:4089–4099.
39. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007;447:1116–1120.
40. Wernstedt Asterholm I, Tao C, Morley TS et al. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab 2014;20:103–118.
41. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117:175–184.
42. Kim D, Kim J, Yoon JH et al. CXCL12 secreted from adipose tissue recruits macro-phages and induces insulin resistance in mice. Diabetologia 2014;57:1456–1465.
43. Surmi BK, Hasty AH. The role of chemo-kines in recruitment of immune cells to the artery wall and adipose tissue. Vascul Pharmacol 2010;52:27–36.
44. Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the de-velopmentofobesity-related insulinresistance. J Clin Invest 2003;112:1821–1830.
45. Zeyda M, Stulnig TM. Adipose tissue mac-rophages. Immunol Lett 2007;112:61–67.
46. Jais A, Einwallner E, Sharif O et al. Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man. Cell 2014; 158:25–40.
47. Nagareddy PR, Kraakman M, Masters SL et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab 2014;19:821–835.
48. Wentworth JM, Naselli G, Brown WA etal. Pro-inflammatory CD11c+CD206+adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010;59: 1648–1656.
49. Tordjman J, Poitou C, Hugol D et al. Association between omental adipose tissue macro-phages and liver histopathology in morbid obesity: Influence of glycemic status. J Hepatol 2009;51:354–362.
50. Patsouris D, Cao JJ, Vial G et al. Insulin resistance is associated with MCP1-mediated macrophage accumulation in skeletal muscle in miceand humans. PLoS One 2014;9:e110653.
51. Kanneganti T-D, Dixit VD. Immunological complications of obesity. Nat Immunol 2012; 13:707–712.
52. Lucas T, Waisman A, Ranjan R et al. Differential rolesofmacrophagesindiversephases of skin repair. J Immunol 2010;184:3964–3977.
53. Duffield JS, Forbes SJ, Constandinou CM et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005;115: 56–65.
54. Lee S, Huen S, Nishio H et al. Distinctmac-rophagephenotypescontributetokidneyinjury and repair. J Am Soc Nephrol 2011;22:317–326.
55. Arnold L, Henry A, Poron F et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007;204:1057–1069.
56. Stefater JA III., Ren S, Lang RA et al. Metchnikoff’s policemen: Macrophages in development, homeostasis and regeneration. Trends Mol Med 2011;17:743–752.
57. VandenBossche J, Lamers WH, Koehler ES et al. Pivotal advance: Arginase-1-independent polyamine production stimulates the expression of IL-4-induced alternatively activated macro-phage markers while inhibiting LPS-induced expression of inflammatory genes. J Leukoc Biol 2012;91:685–699.
58. In’t Veld P, De Munck N, Van Belle K et al. Beta-cell replication is increased in donor organs from young patients after prolonged life support. Diabetes 2010;59:1702–1708.
59. Tessem JS, Jensen JN, Pelli H et al. Critical roles for macrophages in islet angiogenesis and maintenance during pancreatic degeneration. Diabetes 2008;57:1605–1617.
60. Kreider T, Anthony RM, Urban JF Jr et al. Alternatively activated macrophages in helminth infections. Curr Opin Immunol 2007;19: 448–453.
61. Liu Q, Sundar K, Mishra PK et al. Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms. Infect Immun 2009;77:5347–5358.
62. Espinoza-Jiménez A, Rivera-Montoya I, Cárdenas-Arreola R et al. Taenia crassiceps infection attenuates multiple low-dose streptozotocin-induced diabetes. J Biomed Biotechnol 2010;2010:850541.
63. Wu D, Molofsky AB, Liang HE et al. Eosi-nophils sustain adipose alternatively activated macrophages associated with glucose homeo-stasis. Science 2011;332:243–247.
64. Brissova M, Aamodt K, Brahmachary P et al. Islet microenvironment, modulated by vascular endothelial growth factor-A signaling, promotes b cell regeneration. Cell Metab 2014;19:498–511.
65. Xiao X, Gaffar I, Guo P et al. M2 macro-phages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci USA 2014;111:E1211–E1220.
66. Xu X, D’Hoker J, Stange´ G et al. Beta cells canbegeneratedfromendogenousprogenitors in injured adult mouse pancreas. Cell 2008;132: 197–207.
67. Van Gassen N, Van Overmeire E, Leuckx G et al. Macrophage dynamics are regulatedbylo-cal macrophage proliferation and monocyte recruitment in injured pancreas. Eur J Immunol 2015 [Epub ahead of print].
68. Lacey DC, Achuthan A, Fleetwood AJ et al. Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. J Immunol 2012;188:5752–5765.
69. Martinez FO, Gordon S, Locati M et al. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. J Immunol 2006;177:7303–7311.
70. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apo-ptosis in pancreatic islet transplantation: Implications for intrahepatic grafts. J Leukoc Biol 2005;77:587–597.
71. Nikolic T, Geutskens SB, van Rooijen N et al. Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: A phagocyte depletion study. Lab Invest 2005; 85:487–501.
72. Schneider DA, Kretowicz AM, von Her-rath MG. Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation. Diabetes Obes Metab 2013;15:581–592.
73. Vachharajani V, Granger DN. Adipose tissue: A motor for the inflammation associated with obesity. IUBMB Life 2009;61:424–430.
74. Rena G, Pearson ER, Sakamoto K. Molecular mechanism of action of metformin: Old or new insights? Diabetologia 2013;56:1898–1906.
75. Kim J, Kwak HJ, Cha JY et al. Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response inmurine macrophages via activating transcription factor-3 (ATF-3) induction. J Biol Chem 2014;289:23246–23255.
76. Smith U. Pioglitazone: Mechanism of action. Int J Clin Pract Suppl 2001:13–18.
77. Bodles AM, Varma V, Yao-Borengasser A etal. Pioglitazone induces apoptosis of mac-rophages in human adipose tissue. J Lipid Res 2006;47:2080–2088.
78. Ao C, Huo Y, Qi L et al. Pioglitazone suppresses the lipopolysaccharide-induced production of inflammatory factors in mouse macrophages by inactivating NF-kappaB. Cell Biol Int 2010;34:723–730.
79. Lee YS, Park MS, Choung JS et al. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammationin an obese mouse model of diabetes. Diabetologia 2012;55:2456–2468.
80. Shiraishi D, Fujiwara Y, Komohara Y et al. Glucagon-like peptide-1(GLP-1)inducesM2po-larization of human macrophages via STAT3 activation. Biochem Biophys Res Commun 2012; 425:304–308.
81. Noto H, Goto A, Tsujimoto T et al. Latest insights into the risk of cancer in diabetes. J Diabetes Investig 2013;4:225–232.
82. Colwell JA, Lopes-Virella M, Halushka PV. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care 1981;4:121–133.